Chondrodysplasis punctata: is maternal warfarin therapy a factor?
D000014:Abnormalities, Drug-Induced; D000328:Adult; D002806:Chondrodysplasia Punctata / Q000139:chemically induced* / Q000000981:diagnostic imaging; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006350:Heart Valve Prosthesis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010922:Placenta Diseases / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011859:Radiography; D013444:Sulfisoxazole / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D014859:Warfarin; D004077:Digoxin; D013444:Sulfisoxazole; D006493:Heparin; D004074:Digitoxin